Search Results - francis+spinale

4 Results Sort By:
Minimally Invasive and Semi-Automated Myocardial Injection Device
Reference #: 01450 The University of South Carolina is offering licensing opportunities for Minimally Invasive and Semi-Automated Myocardial Injection Device Background: Approximately, 550,000 first episodes and 200,000 recurrent episodes of acute myocardial infarction occur annually. Invention Description: This device is designed and optimized...
Published: 2/28/2024   |   Inventor(s): Francis Spinale, Tarek Shazly, Dara Azar Ahmadi, Heather Trainor
Keywords(s): automatic infusion, automatic needle, cardiac repair, infusion, Injection device, intramyocardial injection therapy, medical device
Category(s): Biomedical and Life Sciences, Health Sciences
Non-Invasive Estimation of the Mechanical Properties of the Heart
Reference #: 01368The University of South Carolina is offering licensing opportunities for Non-Invasive Estimation of the Mechanical Properties of the HeartBackground:Left ventricular remodeling, a mechanistic response to myocardial injury, has been shown to underlie the progression to heart failure. As such, sensitive technique to track the rate and...
Published: 9/3/2024   |   Inventor(s): Tarek Shazly, William Torres, Francis Spinale
Keywords(s):  
Category(s): Biomedical and Life Sciences, Health Sciences
Biomarker panel for Predicting Patient Response to Cardiac Resynchronization Therapy
Inventors have identified a specific and unique set of biomarkers that can be developed into a point of care (POC) diagnostic to predict those patients with a high probability of responding to cardiac resynchronization therapy (CRT). Biomarkers have been identified to support the clinical decision of whether CRT will be a meaningful course of treatment....
Published: 3/22/2023   |   Inventor(s): Craig Stolen, Timothy Meyer, Milan Seth, Francis Spinale
Keywords(s):  
Category(s): BioPharma
Plasma Biomarkers for Predicting Recurrence of Atrial Fibrillation Following Cardioversion
The inventors have developed a panel of biomarkers, including various matrix metalloproteinases (MMPs) and tissue inhibitor matrix metalloproteinases (TIMPs), which can determine patients at risk for recurrent atrial fibrillation (AF). These biomarkers can pre-emptively detect treatment failure for cardioversion activities. These biomarkers can be detected...
Published: 3/22/2023   |   Inventor(s): Rupak Mukherjee, Michael Gold, Francis Spinale
Keywords(s): cardiovascular, diagnostic
Category(s): BioPharma